Batteries play a significant role in the overall safety, performance, and reliability of many life-saving and life-sustaining medical devices. As more medical devices become computerized, compact, and mobile, the number of battery-powered medical devices will continue to increase. While many different components can potentially impact the safety and effectiveness of medical devices, the battery is one of the most critical components. Unexpected depletion or failure of the battery can cause the device to stop functioning properly, preventing the device from delivering life-sustaining or life-saving therapy. The Association for the Advancement of Medical Instrumentation (AAMI) has identified battery management as one of the top 10 challenges for hospital’s biomedical departments.Â
While the FDA has confidence that medical devices currently being marketed will continue to function appropriately, there are opportunities to further improve their overall performance and safety. The FDA organized a Battery-Powered Medical Devices Workshop on July 30-31, 2013 to create awareness of the potential challenges related to battery-powered medical devices and to collaboratively develop ways of ensuring the continued performance and reliability of these devices. The participants included a broad group of stakeholders that are responsible for the design, testing, manufacturing, integration, regulation, selection, purchase, storage, maintenance, and use of batteries throughout the total product life cycle of battery-powered medical devices. The first day focused on the current and future challenges with batteries and battery-powered medical devices. The second day focused on the opportunities, potential solutions, and next steps. Both days included keynote and introductory presentations in the morning intended to encourage further discussion during the breakout sessions in the afternoon.
- Date, Time and Location
- Webcast Archive
- Federal Register Notice
- Agenda
- Registration
- Public Comment
- Contact Us
Campus Information, Travel Information, and Directions
Webcast Archive
Day 1
- Morning session 1: Introductions and Keynotes
- Morning session 2: Challenges
- Webcast session 1: Panel discussion
- Webcast session 2: Panel discussion
Day 2
- Morning session 1: Keynote address and review of Day 1 webcast
- Morning session 2: Opportunities
- Webcast session 3: Panel discussion
- Afternoon session: Future technologies and brainstorming presentations
Ken Skodacek, Co-Leader CDRH’s Battery Working Group, CDRH, FDASetting the Stage for Collaboration BREAK Challenges: Stakeholder Perspectives10:20-10:30AAMI perspective, Alan Lipschultz, CEO, HealthCare Technology Consulting LLC10:30-10:40Health Technology Management Perspective, David Marlow, Certified Biomedical Equipment Technician, University of Michigan Health System10:40-10:50Challenges of a children’s hospital, David Bradley, Director of Biomedical Engineering, Nationwide Children’s10:50-11:00Healthcare Provider Perspective, CDR Mike Krumlauf, USPHS, NIH Clinical Center11:00-11:10ECRI Institute Perspective, Chris Lavanchy, Engineering Director, Health Devices Group, ECRI Institute11:10-11:20FDA Perspective, Hamed Ghods, Engineer, Office of Science and Engineering Laboratories, CDRH, FDA11:20-11:30Medical Device Manufacturer (Implantable), Michael Root, Scientist, Boston Scientific11:30-11:40DoD Challenges with Batteries in a Deployed Environment, MSG Curt Straub, US Army, USAMMA11:40-11:50Battery Manufacturer Perspective, Dominick Frustaci, VP of RD, Greatbatch11:50-12:00Transportation of Lithium batteries, Kevin Leary, International Transportation Specialist, Office of Hazardous Materials Safety, US Department of Transportation12:00-12:20Question and Answer Period / Panel Discussion
Panel: David Bradley, Dominick Frustaci, Hamed Ghods, Kevin Leary, Mike Krumlauf, Chris Lavanchy, Alan Lipschultz, David Marlow, Michael Root, Curt Straub12:20-12:30Brainstorming for Innovation, Andrew Grebe, Innovation Lab, U.S. Office of Personnel Management LUNCH Afternoon Breakout Sessions for In-person and Online Participants
What are the goals? What are the challenges?1:30-3:00Breakout Session 1Â BREAK3:15-4: 45Breakout Session 24:45-5:00Closing Statement and Plans for Day 2Â
Â
Â
Agenda-Day 2, July 31, 2013
Opportunities
8:00-9:00Registration and Networking Morning Presentations
Moderator: Ken Skodacek, Co-Leader CDRH’s Battery Working Group, FDA9:00-9:30Key Note Presentation, Cristin Dorgelo, Assistant Director of Grand Challenges, Office of Science and Technology Policy, Executive Office of the President
Harnessing American Ingenuity through Open Innovation9:30-10:30Presentation and Discussion of Day 1 Brainstorming Sessions BREAK10:40-10:50Human Factors Considerations, Ron Kaye, Team Leader of Human Factors Evaluation Team, Office of Device Evaluation, CDRH, FDA10:50-11:00Battery Standards, Rich Byczek, Global Technical Lead of Electric Vehicle Energy Storage, Intertek11:00-11:10Battery Testing, Bruce Adams, VP of Sales, Cadex11:10-11:20Home Use Devices, Mary Weick-Brady, Senior Policy Advisor, Office of Center Director, CDRH, FDA11:20-11:30Battery/Device integration and technologies that address patient challenges, Alex Fay, Business Development Manager, Quallion11:30-11:40Requirements flow-down from device-to-battery and the related role of battery modeling, Craig Schmidt, Sr. Director Energy Systems, Medtronic11:40-11:50Case for Quality Critical to Quality, CAPT, Kim Lewandowski-Walker, USPHS, National Expert In Medical Devices, ORA, FDA11:50-12:00Education: how can we make an impact, Ron Charnock, CEO, KwikPoint12:00-12:15Q/A and panel discussion
Panel: Bruce Adams, Mary Brady, Rich Byczek, Rich Constantineu, Ron Charnock, Alex Fay, Ron Kaye, Craig Schmidt, Kim Lewandowski Walker LUNCH Afternoon Breakout Sessions for In-person and Online Participants
What are the solutions? What are the next steps?1:15-2:45Breakout Session 3Â BREAKÂ Afternoon Presentations
Moderator: Charles Ho, Co-Leader CDRH’s Battery Working Group, FDA3:15-3:30Highly Resonant Wireless Power Transfer being used to recharge implantable batteries and devices, Colin McCarthy, Product Marketing Specialist, WiTricity3:30-3:45Designing Battery Powered Medical Devices for public health emergencies, Philip Ferro, Director of Special Projects, office of Assistant Secretary of Preparedness and Response, HHS3:45-4:00Human Powered Medical Devices, Mike McAlpine, Assistant Professor, Princeton University4:00-4:45Presentation and Discussion of Day 2 Brainstorming Sessions4:45-5:00Closing Statement and Next Steps
Breakout session details for in-person participants:
The in-person participants were divided into 8 groups. The CDRH staff worked with the subject matter experts to facilitate the brainstorming sessions.
Breakout session details for webcast participants:
During the in-person breakout sessions there was a panel discussion for the benefit of the webcast participants. On each day 5 panelists discussed challenges and opportunities and the webcast participants provided feedback or ask questions to the panel.
Registration to Attend the Workshop
Registration is closed as of July 19, 2013.Â
There is no fee to register for the Workshop and registration will be on a first-come, first-served basis. Early registration is recommended because seating is limited.
Public Comment
In order to permit the widest possible opportunity to obtain public comment, FDA is soliciting either electronic or written comments on all aspects of the public workshop topics. The deadline for submitting comments is by 5 p.m. on August 30, 2013. Regardless of attendance at the meeting, interested persons may submit their comments regarding this workshop at http://www.regulations.gov/#!documentDetail; D=FDA-2013-N-0580-0001 or to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm.1061, Rockville, MD 20852.
Speakers’ and Panelists’ Biographies
[email protected].
For questions regarding workshop content, please contact Dr. Iacovos (Jake) Kyprianou, Center Science Council, Office of Center Director, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 3609, Silver Spring, MD 20993-0002, 301-796-2601, [email protected].
Panel: David Bradley, Dominick Frustaci, Hamed Ghods, Kevin Leary, Mike Krumlauf, Chris Lavanchy, Alan Lipschultz, David Marlow, Michael Root, Curt Straub12:20-12:30Brainstorming for Innovation, Andrew Grebe, Innovation Lab, U.S. Office of Personnel Management LUNCH Afternoon Breakout Sessions for In-person and Online Participants
What are the goals? What are the challenges?1:30-3:00Breakout Session 1Â BREAK3:15-4: 45Breakout Session 24:45-5:00Closing Statement and Plans for Day 2Â
Â
Â
Agenda-Day 2, July 31, 2013
Opportunities
8:00-9:00Registration and Networking Morning Presentations
Moderator: Ken Skodacek, Co-Leader CDRH’s Battery Working Group, FDA9:00-9:30Key Note Presentation, Cristin Dorgelo, Assistant Director of Grand Challenges, Office of Science and Technology Policy, Executive Office of the President
Harnessing American Ingenuity through Open Innovation9:30-10:30Presentation and Discussion of Day 1 Brainstorming Sessions BREAK10:40-10:50Human Factors Considerations, Ron Kaye, Team Leader of Human Factors Evaluation Team, Office of Device Evaluation, CDRH, FDA10:50-11:00Battery Standards, Rich Byczek, Global Technical Lead of Electric Vehicle Energy Storage, Intertek11:00-11:10Battery Testing, Bruce Adams, VP of Sales, Cadex11:10-11:20Home Use Devices, Mary Weick-Brady, Senior Policy Advisor, Office of Center Director, CDRH, FDA11:20-11:30Battery/Device integration and technologies that address patient challenges, Alex Fay, Business Development Manager, Quallion11:30-11:40Requirements flow-down from device-to-battery and the related role of battery modeling, Craig Schmidt, Sr. Director Energy Systems, Medtronic11:40-11:50Case for Quality Critical to Quality, CAPT, Kim Lewandowski-Walker, USPHS, National Expert In Medical Devices, ORA, FDA11:50-12:00Education: how can we make an impact, Ron Charnock, CEO, KwikPoint12:00-12:15Q/A and panel discussion
Panel: Bruce Adams, Mary Brady, Rich Byczek, Rich Constantineu, Ron Charnock, Alex Fay, Ron Kaye, Craig Schmidt, Kim Lewandowski Walker LUNCH Afternoon Breakout Sessions for In-person and Online Participants
What are the solutions? What are the next steps?1:15-2:45Breakout Session 3Â BREAKÂ Afternoon Presentations
Moderator: Charles Ho, Co-Leader CDRH’s Battery Working Group, FDA3:15-3:30Highly Resonant Wireless Power Transfer being used to recharge implantable batteries and devices, Colin McCarthy, Product Marketing Specialist, WiTricity3:30-3:45Designing Battery Powered Medical Devices for public health emergencies, Philip Ferro, Director of Special Projects, office of Assistant Secretary of Preparedness and Response, HHS3:45-4:00Human Powered Medical Devices, Mike McAlpine, Assistant Professor, Princeton University4:00-4:45Presentation and Discussion of Day 2 Brainstorming Sessions4:45-5:00Closing Statement and Next Steps
Breakout session details for in-person participants:
The in-person participants were divided into 8 groups. The CDRH staff worked with the subject matter experts to facilitate the brainstorming sessions.
Breakout session details for webcast participants:
During the in-person breakout sessions there was a panel discussion for the benefit of the webcast participants. On each day 5 panelists discussed challenges and opportunities and the webcast participants provided feedback or ask questions to the panel.
Registration to Attend the Workshop
Registration is closed as of July 19, 2013.Â
There is no fee to register for the Workshop and registration will be on a first-come, first-served basis. Early registration is recommended because seating is limited.
Public Comment
In order to permit the widest possible opportunity to obtain public comment, FDA is soliciting either electronic or written comments on all aspects of the public workshop topics. The deadline for submitting comments is by 5 p.m. on August 30, 2013. Regardless of attendance at the meeting, interested persons may submit their comments regarding this workshop at http://www.regulations.gov/#!documentDetail; D=FDA-2013-N-0580-0001 or to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm.1061, Rockville, MD 20852.
Speakers’ and Panelists’ Biographies
[email protected].
For questions regarding workshop content, please contact Dr. Iacovos (Jake) Kyprianou, Center Science Council, Office of Center Director, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 3609, Silver Spring, MD 20993-0002, 301-796-2601, [email protected].